| Product dosage: 0.1mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.46 | $43.86 (0%) | 🛒 Add to cart |
| 60 | $1.15 | $87.72 $68.80 (22%) | 🛒 Add to cart |
| 90 | $1.04 | $131.58 $93.74 (29%) | 🛒 Add to cart |
| 120 | $0.98 | $175.44 $117.82 (33%) | 🛒 Add to cart |
| 180 | $0.93 | $263.16 $167.70 (36%) | 🛒 Add to cart |
| 270 | $0.90 | $394.74 $241.66 (39%) | 🛒 Add to cart |
| 360 | $0.88
Best per pill | $526.32 $315.62 (40%) | 🛒 Add to cart |
Synonyms | |||
Florinef: Restore Electrolyte Balance and Blood Pressure Control
Florinef (fludrocortisone acetate) is a synthetic corticosteroid with potent mineralocorticoid activity, primarily prescribed for the management of conditions involving aldosterone deficiency and autonomic dysfunction. It is a cornerstone therapy in regulating sodium-potassium balance, increasing blood volume, and supporting hemodynamic stability in patients with adrenal insufficiency, orthostatic hypotension, and other disorders of fluid and electrolyte regulation. By mimicking the action of aldosterone, Florinef promotes renal sodium reabsorption and potassium excretion, offering a targeted physiological approach to correcting underlying endocrine and autonomic imbalances. Its well-established efficacy and predictable pharmacokinetic profile make it a first-line agent in specialized clinical settings requiring precise hormonal replacement.
Features
- Active ingredient: Fludrocortisone acetate 0.1 mg
- Pharmaceutical form: Oral tablet
- Mechanism: Synthetic corticosteroid with high mineralocorticoid and minimal glucocorticoid activity
- Half-life: Approximately 18–36 hours
- Bioavailability: High oral absorption
- Excretion: Primarily renal
Benefits
- Effectively increases plasma volume and improves orthostatic tolerance in patients with autonomic failure
- Restores sodium-potassium balance in adrenal insufficiency syndromes, reducing risk of hyponatremia and hyperkalemia
- Enhances quality of life by reducing symptoms such as dizziness, fatigue, and syncope associated with hypotension
- Provides predictable and sustained hormonal activity due to its long half-life, allowing for once-daily dosing in most cases
- Minimizes glucocorticoid side effects at standard replacement doses, focusing therapy on mineralocorticoid deficiency
Common use
Florinef is indicated for partial replacement therapy for primary and secondary adrenal insufficiency in Addison’s disease and congenital adrenal hyperplasia. It is also widely used off-label for the treatment of orthostatic hypotension, particularly in neurogenic causes such as Parkinson’s disease, multiple system atrophy, and diabetic autonomic neuropathy. In pediatric endocrinology, it may be used in salt-wasting forms of congenital adrenal hyperplasia. Its use is generally reserved for cases where fluidrocortisone’s specific mineralocorticoid effects are clinically warranted.
Dosage and direction
The typical adult dosage for adrenal insufficiency ranges from 0.05 mg to 0.2 mg orally once daily. For orthostatic hypotension, dosing usually begins at 0.1 mg daily and may be titrated upward based on clinical response and tolerability, not exceeding 0.2 mg daily in most cases. Administration in the morning is recommended to align with circadian cortisol rhythm and minimize potential sleep disturbances. Dosage should be individualized based on serum electrolytes, blood pressure response, and signs of edema or hypokalemia. Pediatric dosing is weight-based and must be carefully supervised by a pediatric endocrinologist.
Precautions
Monitor blood pressure, serum sodium, and potassium levels regularly, especially during dose titration. Use with caution in patients with cardiac disease, hypertension, renal impairment, or hepatic dysfunction. Evaluate for signs of fluid overload, such as edema or weight gain. Consider concomitant glucocorticoid replacement in adrenal insufficiency to avoid Addisonian crisis. Elderly patients may be more susceptible to adverse effects such as hypertension and hypokalemia. Avoid abrupt discontinuation to prevent adrenal insufficiency symptoms.
Contraindications
Florinef is contraindicated in patients with systemic fungal infections, known hypersensitivity to fludrocortisone or any component of the formulation, and untreated bacterial or viral infections. It should not be used in patients with uncontrolled hypertension, congestive heart failure, or severe renal disease. Concomitant live vaccines are contraindicated due to immunosuppressive potential.
Possible side effect
Common side effects include hypertension, hypokalemia, fluid retention, headache, and increased sweating. Less frequently, patients may experience muscle weakness, dizziness, insomnia, or gastrointestinal disturbances. Long-term use at high doses may lead to glucocorticoid-like effects such as weight gain, glucose intolerance, or osteoporosis. Rare but serious adverse effects include severe hypokalemia, cardiac arrhythmias, and exacerbation of congestive heart failure.
Drug interaction
Florinef may interact with drugs such as diuretics (potentially exacerbating electrolyte imbalances), anticoagulants (altering coagulation parameters), and insulin or oral hypoglycemics (affecting glycemic control). Concomitant use with other corticosteroids may amplify adverse effects. Drugs that induce CYP3A4 (e.g., rifampin) may reduce Florinef efficacy, while inhibitors may increase its levels. Monitor closely when used with digoxin due to increased risk of arrhythmias from hypokalemia.
Missed dose
If a dose is missed, take it as soon as remembered unless it is nearly time for the next dose. Do not double the dose to make up for a missed one. Consistent daily dosing is important for maintaining electrolyte and hemodynamic stability. Consult a healthcare provider if multiple doses are missed, as this may precipitate symptoms of adrenal insufficiency or orthostatic hypotension.
Overdose
Overdose may manifest as severe hypertension, hypokalemia, edema, cardiac failure, or alkalosis. Management includes discontinuation of Florinef, supportive care, electrolyte correction, and monitoring of vital signs. Hemodialysis is not effective due to high protein binding. In cases of significant toxicity, administer potassium supplements and antihypertensive agents as needed under medical supervision.
Storage
Store at room temperature (20–25°C or 68–77°F) in a dry place, protected from light and moisture. Keep the container tightly closed and out of reach of children. Do not use beyond the expiration date printed on the packaging.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting or changing any medication regimen. Individual patient needs and responses may vary.
Reviews
“Florinef has been life-changing for my orthostatic hypotension. My dizziness and pre-syncope episodes have reduced significantly.” – Patient with autonomic neuropathy
“As an endocrinologist, I find Florinef indispensable for managing salt-wasting adrenal conditions. Dosing requires careful monitoring but outcomes are excellent.” – Healthcare provider
“Effective but requires strict electrolyte follow-up. Not a medication to be taken lightly.” – Clinical pharmacist
